The role of balanced low-protein diet in inhibition of progression of predialysis chronic disease of the kidneys in systemic diseases
- 作者: Milovanov Y.S.1, Lysenko L.V.1, Milovanova L.Y.1, Dobrosmyslov I.A.1, Milovanov Y.S1, Lysenko LV1, Milovanova LY.1, Dobrosmyslov IA1
-
隶属关系:
- 期: 卷 81, 编号 8 (2009)
- 页面: 52-57
- 栏目: Editorial
- ##submission.dateSubmitted##: 09.04.2020
- ##submission.datePublished##: 15.08.2009
- URL: https://ter-arkhiv.ru/0040-3660/article/view/30499
- ID: 30499
如何引用文章
全文:
详细
Material and methods. Forty six patients with stage III-IV of CDK in systemic diseases (33 SLE patients and 13 with systemic vasculitis) were randomized into three groups. Group 1 consisted of 18 patients with CDK (10 with stage III and 8 with stage IV). They received LPD (0.6 g/kg/day) with addition of essential keto/amino acids for 24-48 months. Group 2 of 18 CDK patients with the same stages received the same diet but greater amount of vegetable protein (highly purified soya protein) to 0.3 g/kg/day in highly energetic nutrient mixture. Group 3 - 10 CDK patients (7 with stage III and 3 with stage IV) received free diet. Group 1 and 2 patients received LPD irrespective of the nutrient status assessed basing on anthropometric and other data. Protein consumption and caloric value were estimated by 3-day food diary.
Results. Before diet therapy, out of 46 examinees nutrient status was abnormal in 45.7% patients. Both variants of LPD were well tolerated and nutrient status was corrected while the rate of nutritive disorders in group 3 increased 1.5-fold (from 40 to 60%) with progression of renal failure. Intake of LPD diet for at least a year reduced glomerular filtration rate inhibition, especially in addition of highly energetic mixture.
Conclusion. Early (predialysis) restriction of diet protein (0.6 g/kg/day) with addition of highly energetic mixture and essential keto/amino acids improves a nutritive status of CDK patients and inhibits GFR decline.
作者简介
Yuriy Milovanov
Email: yuriymilovanov@mail.ru
Lidiya Lysenko
Lyudmila Milovanova
Igor' Dobrosmyslov
Yu Milovanov
L Lysenko
L Milovanova
I Dobrosmyslov
参考
- K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am. J. Kidney Dis. 2002; 39 (suppl. 1).
- Klahr S., Levey A. S., Beck G. J. et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. N. Engl. J. Med. 1994: 330: 877-884.
- Kasiske B. L., Lacatua J. D. A., Ma J. Z., Louis T. A. A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. Am. J. Kidney Dis. 1998; 31: 954-961.
- Милованов Ю. С. Хроническая почечная недостаточность. В кн.: Мухин Н. А. и др. (ред.). Рациональная фармакотерапия. М.: Литтерра; 2006. 586-601.
- Zakar G. The effect of ketoacid supplement on the course of cronic renal failure and nutritional parameters in predialysis patients and patients on regular dialysis theraphy: the Hungarian ketosteril cohort study. Wien. Klin. Wschr. 2001; 113: S686-S694.
- Walser M., Hill S. B., Ward L., Magder L. A crossover comparison of progression of chronic renal failure: Ketoacids versus amino acids. Kidney Int. 1993; 43: 933-939.
- Ермоленко В. М., Козлова Т. А., Михайлова Н. А. Значение малобелковой диеты в замедлении прогрессирования хронической почечной недостаточности. Нефрол. и диализ. 2006; 4: 310-320.
- Modification of Diet in Renal Disease (MDRD) Study Group (prepared by Levey A. S., Adler S., Caggiula A. W. et al.). Effects of dietary protein restriction on moderate renal disease in the Modification of Diet on Renal Disease Study. J. Am. Soc. Nephrol. 1996; 7: 2616-2626.
- Modification of Diet on Renal Disease Study Group (prepared by Teschan P. E., Beck G. J., Dwyer J. T. et al.). Effect of ketoacid-amino acid-supplemented very low protein dieton the progression of advanced renal disease: A reanalysis of the MDRD feasibility study. Clin. Nephrol. 1998; 50 (1): 273-283.
- Fouque D., Wang P., Laville M., Boissel J. P. Low-protein diet delay end stage renal disease in non diabetic adults with chronic renal failure. Nephrol. Dial. Transplant. 2000; 15: 1986-1992.
- Laouari D., Kloinknecht C., Broyer M. Utilisation des ketoanalogues d'acides amines dans l'insuffisance renale chronique. Nephrologie 1986; 7: 133-137.
- Милованов Ю. С., Козловская Л. В., Милованова Л. Ю. Нефропротективное значение ранней коррекции нарушений нутритивного статуса у больных с хронической болезнью почек на додиализном этапе. Тер. арх. 2008; 6: 56-60.
- Мухин Н. А., Тареева И. Е., Шилов Е. М. Диагностика и лечение болезней почек. М.: ГЕОТАР-МЕД; 2002.
- Bergesio F., Monzani G., Guasparini A. et al. Cardiovascular risk factors in severe chronic renal failure: the role of dietary treatment. Clin. Nephrol. 2005; 64: 103-112.
- Mich W., Clark A. Specifity of the effect of leucin and its metabolites on protein degradation in skeletal muscle. Biochem. J. 1984; 222: 579-586.
补充文件
![](/img/style/loading.gif)